Lucas Ward
Stock Analyst at Ascendiant
(0.03)
# 4,723
Out of 4,988 analysts
57
Total ratings
15%
Success rate
-54.8%
Average return
Main Sectors:
Stocks Rated by Lucas Ward
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VVOS Vivos Therapeutics | Reiterated: Buy | $3 → $3.1 | $0.176 | +1,661.36% | 12 | Jun 4, 2026 | |
| ACON Aclarion | Reiterated: Buy | $7 → $7.5 | $2.64 | +184.09% | 8 | May 28, 2026 | |
| SXTP 60 Degrees Pharmaceuticals | Reiterated: Buy | $4.2 → $3.7 | $0.9926 | +272.76% | 10 | May 22, 2026 | |
| LIQT LiqTech International | Reiterated: Buy | $4.3 → $4.4 | $0.68995 | +537.73% | 10 | May 20, 2026 | |
| HSCS HeartSciences | Reiterated: Buy | $9.2 → $8 | $4.84 | +65.29% | 12 | Mar 23, 2026 | |
| VMAR Vision Marine Technologies | Reiterated: Buy | $30 → $10 | $7.31 | n/a | 5 | Apr 30, 2025 |
Vivos Therapeutics
Jun 4, 2026
Reiterated: Buy
Price Target: $3 → $3.1
Current: $0.176
Upside: +1,661.36%
Aclarion
May 28, 2026
Reiterated: Buy
Price Target: $7 → $7.5
Current: $2.64
Upside: +184.09%
60 Degrees Pharmaceuticals
May 22, 2026
Reiterated: Buy
Price Target: $4.2 → $3.7
Current: $0.9926
Upside: +272.76%
LiqTech International
May 20, 2026
Reiterated: Buy
Price Target: $4.3 → $4.4
Current: $0.68995
Upside: +537.73%
HeartSciences
Mar 23, 2026
Reiterated: Buy
Price Target: $9.2 → $8
Current: $4.84
Upside: +65.29%
Vision Marine Technologies
Apr 30, 2025
Reiterated: Buy
Price Target: $30 → $10
Current: $7.31
Upside: n/a